InvestSMART

Little Green Pharma Ltd (ASX: LGP) - Announcements

- Current share price for LGP : $0.072

ASX company news and announcements for Little Green Pharma Ltd (LGP) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Little Green Pharma Ltd (LGP) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Little Green Pharma Ltd (LGP), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Little Green Pharma Ltd (LGP)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$60 Quarterly Activities Report and Appendix 4C 22 Jul 2020 9:08AM $0.375 $0.072 fallen by 80.80%
$60 Medicinal Cannabis Permit Granted for Expanded Facility 20 Jul 2020 9:01AM $0.330 $0.072 fallen by 78.18%
$60 Appendix 2A - Exercise of Options and Cleansing Notice 1 Jul 2020 9:54AM $0.350 $0.072 fallen by 79.43%
$60 Appendix 2A - Release from Escrow 1 Jul 2020 9:45AM $0.350 $0.072 fallen by 79.43%
$60 Notice of Release from Escrow 1 Jul 2020 9:42AM $0.350 $0.072 fallen by 79.43%
$60 Change of Company Secretary 1 Jul 2020 9:40AM $0.350 $0.072 fallen by 79.43%
$60 Strategic Shipment Exported to the UK 29 Jun 2020 9:30AM $0.355 $0.072 fallen by 79.72%
$60 Sales Update - April 2020 28 May 2020 9:26AM $0.385 $0.072 fallen by 81.30%
$60 Clarification Statement 13 May 2020 9:42AM $0.410 $0.072 fallen by 82.44%
$60 ODC Manufacturing Permit Granted 11 May 2020 9:15AM $0.335 $0.072 fallen by 78.51%
$60 Proposed issue of Securities - LGP 8 May 2020 5:49PM $0.335 $0.072 fallen by 78.51%
$60 Investor Presentation 30 Apr 2020 8:42AM $0.280 $0.072 fallen by 74.29%
$60 Quarterly Activities Report and Appendix 4C 30 Apr 2020 8:38AM $0.280 $0.072 fallen by 74.29%
$60 Virtual Conference 30 Apr 2020 8:09AM $0.280 $0.072 fallen by 74.29%
$60 First UK Shipment of Australian Medicinal Cannabis Oil 15 Apr 2020 8:57AM $0.295 $0.072 fallen by 75.59%
$60 COVID-19 Business Update 2 Apr 2020 9:53AM $0.270 $0.072 fallen by 73.33%
$60 Commissioning of Cultivation Facility Expansion Complete 26 Mar 2020 9:51AM $0.200 $0.072 fallen by 64%
$60 Investor Presentation 16 Mar 2020 9:35AM $0.280 $0.072 fallen by 74.29%
$60 Expanded Medicinal Licence and new Manufacturing Licence 12 Mar 2020 8:56AM $0.300 $0.072 fallen by 76%
$60 Fourth Medicinal Cannabis Oil Product 2 Mar 2020 8:34AM $0.400 $0.072 fallen by 82%
$60 Appendix 4D and Half Yearly Report 28 Feb 2020 10:34AM $0.400 $0.072 fallen by 82%
$60 German Purchase Agreement with Demecan 27 Feb 2020 9:41AM $0.405 $0.072 fallen by 82.22%
$60 Becoming a substantial holder - Elixxer Ltd 26 Feb 2020 2:41PM $0.400 $0.072 fallen by 82%
$60 Becoming a substantial holder - FS 25 Feb 2020 8:20AM $0.410 $0.072 fallen by 82.44%
$60 Initial Director's Interest Notice - AC 21 Feb 2020 1:52PM $0.445 $0.072 fallen by 83.82%

426 - 450 of 468 results

Page 18 of 19

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.